New Perspectives provides support and leadership for emerging biotechnology and pharmaceutical companies by helping to maximize your developmental assets in the commercial setting.
We help companies build a take-to-market strategy, obtain investment, or package an asset for licensure or sale. Our experience encompasses NCE, 505b2, orphan drugs, BPLA, generics, devices and biosimilars. Whether you are developing your product for licensing or planning on commercializing it yourself, we’re focused on its success. Our team partners with your team to establish your product’s value proposition, differentiate it from the competition and shape your product’s ultimate strategic direction for launch and commercial success.